ConductScience.org, home

Trial · NCT00962949

The Renin-Aldosterone Axis in Postural Tachycardia Syndrome

NCT00962949, Phase 1, Completed, Vanderbilt University Medical Center; results first posted 2018-08-17

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Renin-Aldosterone Axis in Postural Tachycardia Syndrome. Trials, record NCT00962949. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00962949

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
NCT number
NCT00962949
Status
Completed
Phases
Phase 1
Enrollment
28 participants, actual
Lead sponsor
Vanderbilt University Medical Center
Conditions
Postural Orthostatic Tachycardia Syndrome (POTS)
Interventions
Angiotensin II
First posted
2009-08-20
Last updated
2025-09-16
Results first posted
2018-08-17
Limitations and caveats
This was a single center, acute study.

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMean Arterial Blood Pressure Change1 hourChange in MAP from baseline to after 1h of infusion.
SecondaryPlasma Renin Activity1 hourChange in plasma renin activity from baseline to after 1h of infusion.
SecondaryAldosterone Level1 hourChange in aldosterone blood level from baseline to after 1h of infusion.
SecondaryCortisol Level1 hourChange in cortisol blood level from baseline to after 1h of infusion.

Outcomes4

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYMean Arterial Blood Pressure Change1 hourmmHgMEAN
SECONDARYPlasma Renin Activity1 hourmicrograms/deciliterMEAN
SECONDARYAldosterone Level1 hourpicogram/milliliterMEAN
SECONDARYCortisol Level1 hourng/ml/hMEAN

Results by group8

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Mean Arterial Blood Pressure ChangeControl14Standard Error 1mmHg
Mean Arterial Blood Pressure ChangePostural Tachycardia Syndrome10Standard Error 1mmHg
Plasma Renin ActivityControl-0.6Standard Error .2micrograms/deciliter
Plasma Renin ActivityPostural Tachycardia Syndrome-0.9Standard Error 0.2micrograms/deciliter
Aldosterone LevelControl15Standard Error 2picogram/milliliter
Aldosterone LevelPostural Tachycardia Syndrome17Standard Error 1picogram/milliliter
Cortisol LevelControl-1.4Standard Error 0.6ng/ml/h
Cortisol LevelPostural Tachycardia Syndrome-0.7Standard Error 0.6ng/ml/h

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDControl13
Overall StudySTARTEDPostural Tachycardia Syndrome15
Overall StudyCOMPLETEDControl13
Overall StudyCOMPLETEDPostural Tachycardia Syndrome15
Overall StudyNOT COMPLETEDControl0
Overall StudyNOT COMPLETEDPostural Tachycardia Syndrome0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityControl013
Total, all-cause mortalityPostural Tachycardia Syndrome015
Total, other adverse eventsControl013
Total, other adverse eventsPostural Tachycardia Syndrome015
Total, serious adverse eventsControl013
Total, serious adverse eventsPostural Tachycardia Syndrome015

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
22247480DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Postural Tachycardia Syndrome vs Control: deaths from any causeTrial comparisons
Postural Tachycardia Syndrome vs Control: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00962949

GET https://conductscience.org/api/trials/v1/NCT00962949/registered